Case studies

IFBD: Q1 2026 Earnings Release | +17.4% in 15 Days

INFOBIRD CO., LTD$0.92 on Jun 24→$1.08 on Jul 9, 2026

The opportunity

Our system surfaced IFBD on 2026-06-24 as liquidity and positioning shifted ahead of Q1 2026 Earnings Release. With bull probability marked at 50%, the setup wasn’t generic “hope” — it was a disciplined read that the tape was mispricing how this catalyst could resolve.

The forecast

We projected rotation toward $1.08 on the bull path — the level where we'd expect repricing if the bullish thesis on Q1 2026 Earnings Release played out versus the bear floor ($0.98). Snapshot-day entry on an end-of-day basis: $0.92 — the same anchor we score on Top Ideas.

The payoff

Infobird reported Q1 2026 earnings with EPS exactly meeting expectations at -$6.79. The market reacted positively to the in-line results, driving the stock to $1.15 and exceeding the $1.08 bull target, as meeting estimates provided reassurance regarding the company's financial trajectory.

IFBD

Hover to view data

No Data

FIZZ: Q2 2026 Earnings Release | +7.5% in 2 Days

NATIONAL BEVERAGE CORP.$31.00 on Jul 1→$33.33 on Jul 3, 2026

The opportunity

Our system surfaced FIZZ on 2026-07-01 as liquidity and positioning shifted ahead of Q2 2026 Earnings Release. With bull probability marked at 60%, the setup wasn’t generic “hope” — it was a disciplined read that the tape was mispricing how this catalyst could resolve.

The forecast

We projected rotation toward $33.50 on the bull path — the level where we'd expect repricing if the bullish thesis on Q2 2026 Earnings Release played out versus the bear floor ($29.50). Snapshot-day entry on an end-of-day basis: $31.00 — the same anchor we score on Top Ideas.

The payoff

National Beverage reported in-line EPS of $0.44 and announced a special cash dividend of $3.25 per share. Despite the large dividend announcement, the stock remained flat as the in-line earnings results failed to provide a clear directional catalyst.

FIZZ

Hover to view data

No Data

FRME: Yield Curve Normalization Sparks Regional Bank Breakout | +11.49% in 22 Days

FIRST MERCHANTS CORPORATION$38.90 on Jun 3→$43.37 on Jun 25, 2026

The opportunity

On June 3, 2026, regional banking was caught in a tug-of-war. While the broader real estate ecosystem buckled under prolonged high interest rates, we looked at the financial sector's historical resilience during yield curve shifts. FRME stood out, trading at a discounted 12.30x P/E ratio compared to the 13.90x industry average. While the crowd feared deposit beta concerns, we recognized that First Merchants was highly sensitive to the FOMC's upcoming rate trajectory, presenting a mispriced opportunity at a snapshot price of $38.90.

The forecast

Our analysis mapped out a clear path tied to the June 17, 2026 FOMC meeting. A steepening yield curve would support net interest margin expansion, driving FRME shares past their initial resistance of $40.31 toward a bull target of $42.00. Conversely, if a hawkish surprise delayed rate cuts and reignited deposit flight fears, we identified a bear floor down at $38.50. The catalyst hinged entirely on the market's assessment of the Fed's rate trajectory and its direct impact on regional bank margins.

The payoff

The thesis played out beautifully by the June 25, 2026 outcome date. FRME did not just reach the bull target; it surged past it to close at $43.37, delivering a realized return of 11.49% from our $38.90 entry in just 22 days. This rally was supercharged by positive sentiment surrounding a new $2,000,000,000.00 Community Benefits Agreement with the NCRC to expand its Midwest impact. Investors shrugged off a minor insider sale, focusing instead on the bank's strong dividend profile and its favorable positioning along the evolving Fed rate trajectory.

FRME

Hover to view data

No Data

AGYS: Fiscal Q4 2026 Earnings Release & FY27 Guidance | +33.6% in 70 Days

AGILYSYS, INC.$65.61 on Apr 8→$87.66 on Jun 17, 2026

The opportunity

Our system surfaced AGYS on 2026-04-08 as liquidity and positioning shifted ahead of Fiscal Q4 2026 Earnings Release & FY27 Guidance. With bull probability marked at 55%, the setup wasn’t generic “hope” — it was a disciplined read that the tape was mispricing how this catalyst could resolve.

The forecast

We projected rotation toward $84.00 on the bull path — the level where we'd expect repricing if the bullish thesis on Fiscal Q4 2026 Earnings Release & FY27 Guidance played out versus the bear floor ($60.00). Snapshot-day entry on an end-of-day basis: $65.61 — the same anchor we score on Top Ideas.

The payoff

Agilysys delivered a strong Q4 double beat, featuring record revenue of $82.90 million, 18% subscription growth, and significant EBITDA margin expansion. The company also issued optimistic FY27 guidance calling for 14-16% revenue growth and 30%+ subscription growth, which shattered investor fears regarding AI disruption and drove a massive rally well past the bull target.

AGYS

Hover to view data

No Data

CGON: FDA BLA Acceptance Catalyst Sparks Rally | +8.4% in 2 Days

CG ONCOLOGY, INC. COMMON STOCK$54.92 on Jun 10→$59.56 on Jun 12, 2026

The opportunity

We flagged CGON at a snapshot price of $54.92 on 2026-06-10. The stock was sitting near a technical base of $55.53 with its RSI deeply oversold at 29.9. While the broader market waited on the sidelines, we identified an impending high-impact catalyst: the expected FDA decision on accepting the rolling Biologics License Application (BLA) for Cretostimogene, alongside its Priority or Standard Review designation.

The forecast

The path forward hinged on this binary regulatory milestone. A formal BLA acceptance and potential Priority Review was projected to serve as a major de-risking event, clearing the way for a relief rally toward the bull target of $68.00 (aligned with the 50-day SMA). Conversely, a Refuse to File (RTF) letter posed a downside risk, threatening to drag the high-beta stock down to its 200-day SMA at $46.00.

The payoff

By the target date of 2026-06-12, CGON climbed to $59.56, delivering an 8.4% return (8.45% realized return) from our snapshot entry. The rally was fueled by positive investor sentiment following management presentations at the Jefferies and Goldman Sachs Global Healthcare Conferences, where the CEO highlighted upcoming clinical milestones, Phase 3 data readouts, and commercial preparations for Cretostimogene in non-muscle invasive bladder cancer (NMIBC).

CGON

Hover to view data

No Data

GEN: Q4 FY2026 Earnings & FY2027 Guidance Update | +14.4% in 21 Days

GEN DIGITAL INC.$23.18 on May 14→$26.52 on Jun 4, 2026

The opportunity

Our system surfaced GEN on 2026-05-14 as liquidity and positioning shifted ahead of Q4 FY2026 Earnings & FY2027 Guidance Update. With bull probability marked at 52%, the setup wasn’t generic “hope” — it was a disciplined read that the tape was mispricing how this catalyst could resolve.

The forecast

We projected rotation toward $26.10 on the bull path — the level where we'd expect repricing if the bullish thesis on Q4 FY2026 Earnings & FY2027 Guidance Update played out versus the bear floor ($20.40). Snapshot-day entry on an end-of-day basis: $23.18 — the same anchor we score on Top Ideas.

The payoff

Gen Digital delivered strong Q4 results, crossing $5.00 billion in FY26 revenue with double-digit growth and a 121% surge in Trust-Based Solutions revenues. The company also raised its FY27 guidance for both revenue and EPS. Despite the robust fundamental beat and raised outlook, the stock remained flat, likely as the market digested the technically overbought setup that preceded the print.

GEN

Hover to view data

No Data

BOOT: Q4 2026 Earnings Release & FY2027 Outlook | +11.5% in 17 Days

BOOT BARN HOLDINGS, INC.$153.10 on May 11→$170.77 on May 28, 2026

The opportunity

Our system surfaced BOOT on 2026-05-11 as liquidity and positioning shifted ahead of Q4 2026 Earnings Release & FY2027 Outlook. With bull probability marked at 55%, the setup wasn’t generic “hope” — it was a disciplined read that the tape was mispricing how this catalyst could resolve.

The forecast

We projected rotation toward $172.50 on the bull path — the level where we'd expect repricing if the bullish thesis on Q4 2026 Earnings Release & FY2027 Outlook played out versus the bear floor ($154.50). Snapshot-day entry on an end-of-day basis: $153.10 — the same anchor we score on Top Ideas.

The payoff

Boot Barn delivered strong Q4 results, featuring an 18.7% jump in sales, better-than-expected same-store growth, and in-line EPS of $1.46. The stock rallied past the bull target as investors cheered the company's robust 14.1% e-commerce growth, expanding merchandise margins driven by exclusive brands, and aggressive plans to open 70 new stores in fiscal 2027.

BOOT

Hover to view data

No Data

TRGP: Guidance Raise Powers Midstream Breakout | +7.23% in 13 Days

TARGA RESOURCES CORP.$252.44 on May 7→$270.69 on May 20, 2026

The opportunity

Heading into its Q1 2026 earnings on May 7, 2026, Targa Resources Corp. (TRGP) was trading at a premium valuation of $252.44, right near its 52-week highs. While the broader market debated whether seasonally softer natural gas liquids (NGL) prices would drag on performance, we focused on the underlying strength of Permian Basin throughput. Strong upstream activity from peers suggested that midstream volume and fee growth remained highly robust, setting up a high-stakes catalyst for the upcoming EBITDA guidance update.

The forecast

Our analysis mapped out a clear path: if Targa could defend or expand its multiple by showing a credible path to flat-to-up Adjusted EBITDA relative to 2025's record levels, the stock could target a bull price of $265.50. Conversely, any unexpected crack in Permian volume growth or a lower fee-based mix threatened to pull shares down to a bear floor of $243.00. The key was whether Permian NGL volumes and fractionation spreads were tracking ahead of plan.

The payoff

The payoff materialized quickly by the May 20, 2026 target date. Although TRGP initially delivered a mixed Q1 2026 report—missing consensus estimates on both earnings and revenue—the underlying fundamentals told a far stronger story. Targa reported record first-quarter net income and raised its full-year 2026 financial outlook, driven by surging NGL transport volumes. Investors shrugged off the immediate top-line miss to focus on the upgraded guidance, propelling the stock to an exit price of $270.69—surpassing our bull target and delivering a realized return of +7.23% over the 13-day hold horizon.

TRGP

Hover to view data

No Data

CPAY: Earnings Beat Drives Surge | +7.4% in 8 Days

CORPAY, INC.$305.75 on May 7→$328.23 on May 15, 2026

The opportunity

Heading into the Q1 2026 print, CPAY faced a wall of worry regarding SME spending and competitive intensity in the B2B payments space. While the company had a history of double-digit growth, recent peer volatility left the stock trading at 305.75 as investors questioned if the organic volume growth could withstand a shifting macro environment.

The forecast

The forecast centered on a bull target of 326, contingent on a clean beat and a confident update to the 2026 outlook. Analysts anticipated a post-print range between 292.00 and 326.00, with the path to the upper bound requiring management to defend margins and prove that the Corporate Payments segment could still outpace the broader market.

The payoff

The payoff arrived on May 15, 2026, as CPAY surged to 328.23 following a dominant Q1 performance. The company reported 25% revenue growth and a 46% year-over-year explosion in Corporate Payments, prompting management to raise full-year guidance. This fundamental strength triggered a 7.35% realized return, clearing the initial bull target within the 8-day window.

CPAY

Hover to view data

No Data

CVS: Earnings Beat & Guidance Raise | +12.2% in 3 Days

CVS HEALTH CORPORATION$80.69 on May 5→$90.55 on May 8, 2026

The opportunity

Heading into the Q1 2026 print, CVS was testing its 52-week high of $83.90 while the market weighed a crucial tug-of-war. Investors were laser-focused on whether the integration of GLP-1 prescription volumes through Caremark could offset the rising tide of Medicare utilization costs within the Aetna division. With shares trading at $80.69, the setup hinged on management’s ability to leverage a recent CMS rate tailwind to stabilize margins and provide clear forward guidance.

The forecast

The path forward was binary: a confident full-year guide and improved medical cost ratios would clear the way to a bull target of $85.50. Conversely, if retail margin erosion or persistent insurance cost pressures surfaced, we anticipated a valuation reset toward a floor of $78.50. The primary catalyst remained the Q1 operational update, specifically how Aetna managed its Medical Loss Ratio (MLR) amid shifting subscriber costs.

The payoff

CVS delivered a decisive beat on May 6, reporting revenues exceeding $100.00 billion and adjusted EPS of $2.57—significantly topping the $2.21 consensus estimate. The stock didn't just hit the bull target; it surged to $90.55 by May 8 as management raised full-year 2026 guidance. This rally, driven by effective medical cost controls in the Aetna division that addressed key market concerns, secured a 12.2% return in just four days, outperforming the initial $85.50 target by 5.9%.

CVS

Hover to view data

No Data

TXT: Q1 2026 Earnings & FY2026 Guidance Update | +7.5% in 3 Days

TEXTRON INC.$88.14 on Apr 28→$94.72 on May 1, 2026

The opportunity

Our system surfaced TXT on 2026-04-28 as liquidity and positioning shifted ahead of Q1 2026 Earnings & FY2026 Guidance Update. With bull probability marked at 55%, the setup wasn’t generic “hope” — it was a disciplined read that the tape was mispricing how this catalyst could resolve.

The forecast

We projected rotation toward $92.50 on the bull path — the level where we'd expect repricing if the bullish thesis on Q1 2026 Earnings & FY2026 Guidance Update played out versus the bear floor ($85.00). Snapshot-day entry on an end-of-day basis: $88.14 — the same anchor we score on Top Ideas.

The payoff

Textron’s Q1 EPS came in exactly at the Street estimate ($1.31 vs. $1.31), so there was no clear earnings beat or miss from the headline number. The stock reaction was muted because the quarter looked broadly in line with expectations, with investor focus centered on whether Aviation margins and defense backlog would show enough early FY2026 progress to justify upside, while the only confirmed corporate update around the event was a routine quarterly dividend declaration.

TXT

Hover to view data

No Data

BULL: Earnings Catalyst Sparks Mean Reversion | +36.63% in 29 Days

WEBULL CORPORATION CLASS A ORDINARY SHARES$5.05 on Mar 26→$6.90 on Apr 24, 2026

The opportunity

On March 26, 2026, Webull Corporation (BULL) traded at a snapshot price of $5.05, sitting just below its 52-week low of $5.13. While the crowd focused on short-term pressure, our analysis highlighted a massive divergence: BULL was growing revenue at a rapid 53.38% clip. With an RSI flashing deeply oversold at 36.60 and a discounted cash flow (DCF) valuation estimated at $35.20, the stock was primed for a violent mean reversion.

The forecast

The catalyst was set for the Q4 2025 earnings release and 2026 forward guidance, expected to benefit from a pro-growth regulatory environment under President Trump's administration. Scouter identified a bull target of $6.80, which sat outside the standard ±1 SD band of $6.02 (the bear floor is not shown in data). The path relied on the market recognizing the company's underlying growth trajectory during the earnings call.

The payoff

The thesis played out rapidly. By the April 24, 2026 target date, BULL surged past the bull target of $6.80 to close at $6.90. Investors who entered at the snapshot price of $5.05 secured a 36.63% return in just 29 days, proving the power of identifying high-growth companies trading at deep technical discounts.

BULL

Hover to view data

No Data

ALL: Weathering the Storm | +6.4% in 34 Days

THE ALLSTATE CORPORATION$205.03 on Mar 12→$218.23 on Apr 15, 2026

The opportunity

On March 12, ALL sat at 205.03 as the market awaited the Q1 2026 catastrophe loss assessment. While the crowd braced for winter volatility, we flagged an asymmetric opportunity: a benign weather outcome would confirm an improving combined ratio and trigger a breakout above 52-week resistance.

The forecast

The forecast centered on the March 25 assessment with a bull target of 218. The path relied on the market pricing in improved underwriting margins ahead of the Q1 earnings report, assuming minimal catastrophe losses would provide the fundamental fuel needed to clear technical hurdles.

The payoff

By April 15, ALL reached 218.23, delivering a 6.4% return. The company reported estimated February catastrophe losses of just $140.00 million, signaling fundamental stability. Although institutional selling from major holders like CalPERS eventually capped the momentum, the stock successfully hit the bull target window.

ALL

Hover to view data

No Data

ESE: Industrial Execution Defies Budget Fears | +15.2% in 10 Days

ESCO TECHNOLOGIES INC.$268.99 on Mar 30→$309.80 on Apr 9, 2026

The opportunity

We flagged ESE at 268.99 just ahead of a high-stakes US Government budget review. While the broader market braced for potential contract setbacks under shifting federal priorities, the setup highlighted a significant Divergence Driver: the company's revenue and backlog growth appeared to be decoupling from macro fears.

The forecast

The forecast established a bull target of 290, banking on the strength of industrial execution to offset federal timing uncertainties. Analysts looked for the stock to stay within a standard expected move of 14.39, with the bull case underpinned by the belief that the company's core utility and stealth programs would remain insulated from budget volatility.

The payoff

By the April 9 target window, the feared procurement risks failed to materialize into a negative catalyst. Instead, ESE benefited from constructive news flow, including the launch of the Spark P2 handheld diagnostic device by its Doble subsidiary. The stock climbed to 309.8, representing a 15.17% realized return and finishing well above the initial bull target.

ESE

Hover to view data

No Data

CDE: Annual Reserve and Resource Update | +18.2% in 6 Days

COEUR MINING, INC.$16.17 on Mar 26→$19.11 on Apr 1, 2026

The opportunity

Our system surfaced CDE on 2026-03-26 as liquidity and positioning shifted ahead of Annual Reserve and Resource Update. With bull probability marked at 75%, the setup wasn’t generic “hope” — it was a disciplined read that the tape was mispricing how this catalyst could resolve.

The forecast

We projected rotation toward $19.09 on the bull path — the level where we'd expect repricing if the bullish thesis on Annual Reserve and Resource Update played out versus the bear floor ($16.67). Snapshot-day entry on an end-of-day basis: $16.17 — the same anchor we score on Top Ideas.

The payoff

Coeur Mining delivered strong fundamental updates, reporting Q4 revenue up 120% and adjusted EPS up 218%, while successfully completing its New Gold acquisition and updating its mineral reserves. The company also issued robust 2026 guidance projecting $2.00 billion in free cash flow, launched a $750.00 million share buyback, and initiated a dividend. Despite these highly bullish operational results, the stock's upside was constrained by sharp declines in underlying gold and silver prices stemming from broader macroeconomic tensions.

CDE

Hover to view data

No Data

HLT: Hospitality Giant Surges on MGM Integration | +3.62% in 5 Days

HILTON WORLDWIDE HOLDINGS INC.$292.58 on Mar 20→$303.16 on Mar 25, 2026

The opportunity

On March 20, 2026, HLT traded at $292.58 under technical pressure, with an RSI of 35.6 signaling oversold conditions. While a high debt-to-equity ratio kept investors sensitive to potential delays in high-margin revenue, the market overlooked a prime setup ahead of a major catalyst: management's upcoming integration and loyalty program update with the MGM Collection.

The forecast

Our analysis mapped a path toward a bull target of $305.00, contingent on management demonstrating strong cross-pollination efficiency with the MGM partnership. Clear execution on this high-margin integration was expected to trigger a rapid technical rebound from oversold levels, offsetting debt concerns and restoring investor confidence.

The payoff

By March 25, 2026, the catalyst delivered. HLT climbed to $303.16, representing a +3.62% gain in just 5 days and nearly hitting our $305.00 bull target. The rally was fueled by positive MGM integration metrics, an exclusive global partnership with YOTEL, the launch of the Hilton AI Planner, and new management contracts that solidified the company's growth trajectory.

HLT

Hover to view data

No Data

DSGX: Logistics Tech Rallies Post-Earnings | +11.9% in 22 Days

THE DESCARTES SYSTEMS GROUP INC.$63.58 on Feb 24→$71.16 on Mar 18, 2026

The opportunity

On February 24, 2026, we flagged DSGX at a snapshot price of $63.58. The market's attention was locked on the upcoming Q4 FY2026 earnings and FY2027 outlook scheduled for March 11, 2026. With a history of steady beats and organic growth accelerating to 7% in Q3, the company demonstrated that its mission-critical logistics network remained highly resilient. Investors were watching closely to see if a robust M&A pipeline could continue to justify its premium valuation multiples.

The forecast

The forecast established a bull target of $75.00, while the bear floor was not shown in data. The path to this target was heavily tied to the March 11 catalyst. A strong earnings beat and solid organic growth guidance were expected to trigger a short-term relief rally back toward former resistance levels, whereas a growth slowdown would likely confirm the stock's recent technical breakdown.

The payoff

The opportunity played out rapidly. By the target window on March 18, 2026, DSGX climbed from its entry price of $63.58 to an exit price of $71.16. This movement secured an 11.92% return over the 22-day holding period, finishing just 5.12% below the initial bull target of $75.00 as the market responded favorably to the earnings event.

DSGX

Hover to view data

No Data

KFY: Fiscal Q3 2026 Earnings Release | +1.9% in 17 Days

KORN FERRY$59.54 on Feb 24→$60.68 on Mar 13, 2026

The opportunity

Our system surfaced KFY on 2026-02-24 as liquidity and positioning shifted ahead of Fiscal Q3 2026 Earnings Release. With bull probability marked at 60%, the setup wasn’t generic “hope” — it was a disciplined read that the tape was mispricing how this catalyst could resolve.

The forecast

We projected rotation toward $66.00 on the bull path — the level where we'd expect repricing if the bullish thesis on Fiscal Q3 2026 Earnings Release played out versus the bear floor ($59.50). Snapshot-day entry on an end-of-day basis: $59.54 — the same anchor we score on Top Ideas.

The payoff

Price reached or fell below bear floor ($59.50) at outcome date.

KFY

Hover to view data

No Data

SJM: Earnings Beat and Activist Agreement Spark Rally | +4.45% in 8 Days

THE J. M. SMUCKER COMPANY$106.60 on Feb 25→$111.34 on Mar 5, 2026

The opportunity

Heading into the Q3 print, SJM sat at a significant discount compared to its intrinsic value, with the market skeptical of the Hostess acquisition integration. We flagged the name as a potential recovery play, betting that synergy realization and coffee pricing power would outweigh volume concerns and a bearish sentiment overhang.

The forecast

The bull case targeted 112.00, predicated on a normalized EPS beat and a confirmed deleveraging timeline from the Hostess deal. Conversely, the bear floor sat lower if integration costs or volume softness forced a major guidance cut, potentially stalling the stock's recovery toward the analyst consensus of 113.33.

The payoff

SJM delivered a double beat, reporting adjusted EPS of 2.38 against the 2.27 consensus and 7% sales growth. Despite a manufacturing facility fire that lowered sales forecasts, the stock climbed to 111.34 by March 5, 2026. Investors cheered the maintained EPS guidance and a constructive agreement with Elliott Management to appoint two new directors, resulting in a 4.45% realized return from the 106.60 entry.

SJM

Hover to view data

No Data

RELY: Remitly Surges on Massive Earnings Beat | +24.62% in 6 Days

REMITLY GLOBAL, INC.$13.08 on Feb 17→$16.30 on Feb 23, 2026

The opportunity

On February 17, 2026, we flagged RELY at a snapshot price of $13.08 ahead of its Q4 2025 earnings report. While the market sought confirmation of consistent GAAP profitability and a 20%+ revenue growth forecast to justify its valuation, strong customer adoption and volume growth in key corridors like India and Mexico set the stage for a potential earnings beat.

The forecast

The forecast established a bull target of $15.50, driven by the potential for Remitly to prove its operational scale. A bear floor was not shown in data, but we warned that a cautious outlook or any deceleration in revenue growth, combined with continued insider selling, would trigger a swift valuation reset.

The payoff

By the outcome date on February 23, 2026, RELY surged to $16.30, delivering a +24.62% return from our snapshot entry in just 6 days and outperforming the bull target of $15.50 by 5.16%. This massive move was triggered by a blockbuster earnings beat of $0.19 per share against a $0.02 estimate, robust 2026 guidance for double-digit revenue growth, and the appointment of new CEO Sebastian J. Gunningham, which reinforced long-term investor confidence.

RELY

Hover to view data

No Data

GPN: Asymmetric Bounce on Earnings | +18.20% in 3 Days

GLOBAL PAYMENTS INC.$69.77 on Feb 17→$82.47 on Feb 20, 2026

The opportunity

Heading into its Q4 2025 earnings release, GPN sat near its 52-week low with a depressed P/E ratio, setting an incredibly low bar for a positive surprise. While the crowd remained cautious, Scouter flagged the opportunity on February 17, 2026, when the stock was trading at $69.77. The catalyst hinged on organic revenue growth, margin expansion post-divestiture, and strong free cash flow (FCF) allocated toward debt reduction. With an oversold RSI, any positive commentary on FCF conversion and accelerated debt payoff set the stage for an asymmetric bounce.

The forecast

The setup pointed to a bull target of $77.00, driven by the potential for a double beat and constructive FY2026 guidance. Conversely, the fallback scenario accounted for potential consolidation or a bearish turn if management issued weak macro guidance or showed continued underperformance in core segments. The critical path relied on management delivering realistic, solid growth rather than triggering the default bearish consolidation rule associated with weak, single-digit growth guidance.

The payoff

The bullish thesis played out rapidly following the February 18, 2026 release. By the outcome date of February 20, 2026, GPN surged past its bull target of $77.00 to close at $82.47. This swift move delivered a realized return of 18.20% from the snapshot entry price of $69.77 in just 3 days, proving how quickly oversold sentiment can reverse on a strong fundamental catalyst.

GPN

Hover to view data

No Data

WELL: Senior Housing Giant Beats Estimates | +10.29% in 8 Days

WELLTOWER INC.$191.06 on Feb 5→$210.72 on Feb 13, 2026

The opportunity

The Opportunity: Heading into its Q4 2025 earnings release, WELL was trading at a premium valuation of $191.06. While some market participants worried that high expectations were already priced in, our analysis focused on the massive operational momentum within the Seniors Housing Operating Portfolio (SHOP). We recognized that a solid FFO/AFFO beat combined with robust 2026 guidance could easily propel the stock higher, despite potential headwinds from labor or financing costs.

The forecast

The Forecast: The setup demanded a clear fundamental catalyst. To validate the premium valuation and reach our bull target of $195.00, WELL needed to deliver a clean sweep: a strong FFO beat and robust 2026 Same-Store Net Operating Income (SS-NOI) guidance. If management confirmed the post-pandemic recovery thesis with aggressive projections, the path to the target was clear; conversely, any disappointment in labor costs would establish a firm floor for risk management.

The payoff

The Payoff: The catalyst played out exactly as anticipated. On February 10, 2026, Welltower delivered a massive fundamental beat, reporting Q4 FFO and revenue well above consensus estimates. Crucially, the company issued 2026 FFO guidance that exceeded analyst expectations, backed by a robust 15% Same-Store NOI growth in its senior housing portfolio. By the target date of February 13, 2026, the stock surged past our $195.00 bull target to close at $210.72, securing a +10.29% return in just 8 days.

WELL

Hover to view data

No Data